[Skip to Navigation]
Sign In
January 21, 2021

Data Errors in Abstract and Results Section

JAMA Oncol. 2021;7(3):466. doi:10.1001/jamaoncol.2020.8157

In the article titled “Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)”1 published online December 3, 2020, in JAMA Oncology, there was incorrect data presented in the Abstract and Results section regarding the number of deaths at 6 months, 6-month OS, and median OS. This article was corrected online.

Ramaswamy  A, Ostwal  V, Sharma  A,  et al.  Efficacy of capecitabine plus irinotecan vs irinotecan monotherapy as second-line treatment in patients with advanced gallbladder cancer: a multicenter phase 2 randomized clinical trial (GB-SELECT).   JAMA Oncol. Published online December 3, 2020. doi:10.1001/jamaoncol.2020.6166PubMedGoogle Scholar